Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Al-Dhfyan, Abdullah  [Clear All Filters]
2022
Al-Dhfyan A, Alaiya A, Al-Mohanna F, Attwa MW, AlAsmari AF, Bakheet SA, Korashy HM. Crosstalk Between Aryl Hydrocarbon Receptor (AhR) and BCL-2 Pathways Suggests the Use of AhR Antagonist to Maintain Normal Differentiation State of Mammary Epithelial Cells During BCL-2 Inhibition Therapy. J Adv Res. 2022.
2020
Akhtar S, Hourani S, Therachiyil L, Al-Dhfyan A, Agouni A, Zeidan A, Uddin S, Korashy HM. Epigenetic Regulations of Cancer Stem Cells by the Aryl Hydrocarbon Receptor Pathway. Semin Cancer Biol. 2020.
2016
Abdel-Aziz HA, Eldehna WM, Ghabbour H, Al-Ansary GH, Assaf AM, Al-Dhfyan A. Synthesis, Crystal Study, and Anti-Proliferative Activity of Some 2-Benzimidazolylthioacetophenones towards Triple-Negative Breast Cancer MDA-MB-468 Cells as Apoptosis-Inducing Agents. Int J Mol Sci. 2016;17(8).
Radwan AA, Al-Mohanna F, Alanazi FK, Manogaran PS, Al-Dhfyan A. Target β-catenin/CD44/Nanog axis in colon cancer cells by certain N'-(2-oxoindolin-3-ylidene)-2-(benzyloxy)benzohydrazides. Bioorg Med Chem Lett. 2016.
2015
Bhat MA, Al-Dhfyan A, Naglah AM, Khan AAli, Al-Omar MA. Lead Optimization of 2-Cyclohexyl-N-[(Z)-(3-methoxyphenyl/3-hydroxyphenyl) methylidene]hydrazinecarbothioamides for Targeting the HER-2 Overexpressed Breast Cancer Cell Line SKBr-3. Molecules. 2015;20(10):18246-18263.
2013
Al-Dhfyan A. Embryonic signature in breast cancers; Pluripotency roots of cancer stem cells. Saudi Pharm J. 2013;21(2):229-32.